EUVIMEDEUVIMED entdecken
Open Access

A polyvalent vaccine for selectively killing tumor-associated bacteria to prevent cancer metastasis

Zheyu Kang iD, Linfu Chen iD, Pengxing Li iD, Zixuan Zheng iD, Jingjing Shen iD, Zhisheng Xiao iD, Yu Miao, Yang Yang, Qian Chen iD

Science Advances · 14.03.2025 · 11 (11)

DOI: 10.1126/sciadv.adt0341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 14.03.2025. Verfasst von Zheyu Kang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow Universit…. Hauptthemen laut MEDLINE: Cancer Vaccines, Bacterial Vaccines, Breast Neoplasms, Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Specific bacteria, including Fusobacterium nucleatum , Streptococcus sanguis , Enterococcus faecalis , and Staphylococcus xylosus , have been identified as contributors to breast cancer metastasis. Due to limitations such as lack of selectivity, traditional antibiotic therapies face obstacles in eliminating intratumoral bacteria. Herein, this work proposes the use of therapeutic vaccines to selectively target and eliminate harmful bacteria within tumors. A multivalent vaccine encapsulating both insoluble and soluble bacterial antigens was developed, addressing the shortcomings of traditional antibacterial vaccines by balancing broad antigen coverage with effective immune activation. This vaccine induces robust downstream immune responses to eliminate F. nucleatum , S. sanguis , E. faecalis , and S. xylosus , demonstrating notable therapeutic and preventive efficacy in bacteria-induced cancer metastasis models. Unexpectedly, vaccinated infected mice showed even slower tumor metastasis than uninfected mice. Overall, this study validates the potential of nanovaccines in modulating the intratumoral microbiome for tumor therapy and highlights tumor-associated bacterial infections as potential promising antitumor targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesBacterial VaccinesBreast NeoplasmsNeoplasmsAnimalsMiceFemaleNeoplasm MetastasisHumansCell Line, TumorAntigens, Bacterial

Substanzen

Cancer VaccinesBacterial VaccinesAntigens, Bacterial

Autor:innen und Institutionen

  • Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.
  • Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
  • Central Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
  • School of Materials Science and Engineering, Tongji University, Shanghai 201804, China.

ORCID-Profile: Zheyu Kang, Linfu Chen, Pengxing Li, Zixuan Zheng, Jingjing Shen, Zhisheng Xiao, Qian Chen

Zitieren

APA

Kang, Z., Chen, L., Li, P., Zheng, Z., Shen, J., Xiao, Z., Miao, Y., Yang, Y., & Chen, Q. (2025). A polyvalent vaccine for selectively killing tumor-associated bacteria to prevent cancer metastasis. Science Advances, 11(11). https://doi.org/10.1126/sciadv.adt0341

Vancouver

Kang Z, Chen L, Li P, Zheng Z, Shen J, Xiao Z, et al. A polyvalent vaccine for selectively killing tumor-associated bacteria to prevent cancer metastasis. Science Advances. 2025;11(11). doi:10.1126/sciadv.adt0341

BibTeX
@article{Kang2025,
  author = {Kang, Zheyu and Chen, Linfu and Li, Pengxing and Zheng, Zixuan and Shen, Jingjing and Xiao, Zhisheng and Miao, Yu and Yang, Yang and Chen, Qian},
  title = {A polyvalent vaccine for selectively killing tumor-associated bacteria to prevent cancer metastasis},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {11},
  doi = {10.1126/sciadv.adt0341}
}
Kostenlos starten →